[graphic omitted]
1245 "Q" Street
Lincoln, NE 68508
Phone: 402-475-2525
Fax: 402-475-9061
Contact: | Patrick E. Beans Chief Financial Officer 402-475-2525 |
NATIONAL RESEARCH CORPORATION REPORTS
FIRST QUARTER RESULTS
LINCOLN, Nebraska (May 4, 2004) — National Research Corporation (NASDAQ/NM:NRCI), a leader in healthcare performance measurement, today announced results for the first quarter ended March 31, 2004.
Commenting on the first quarter results, Michael D. Hays, president and chief executive officer of National Research Corporation, said, “The Company’s strong first quarter performance is a good start to what we expect to be an excellent year. Also, I am pleased to report that our ramped-up sales infrastructure is proactively responding to escalating demand. Those factors, combined with our major expansion of products, which is creating new avenues of additional growth, position us well to achieve our financial goals for the full year.” Mr. Hays also reported that The National Quality Initiative reached 3,429 hospital enrollees, up 26% from the last report, and is expected to reach 4,000 hospitals by June 1, 2004.
Revenues for the first quarter ended March 31, 2004, increased 24.8% to $7.6 million compared with revenues of $6.1 million for the first quarter of 2003. Net income for the first quarter of 2004 increased 27.6% to $1.2 million compared with net income of $921,000 for the same period in 2003, resulting in earnings per share of $0.16 per basic and diluted share for the first quarter of 2004.
Patrick E. Beans, chief financial officer of National Research Corporation, added, “Based upon the excellent start for 2004, we are confident that the remainder of the year will continue this favorable trend. We expect net income for the second quarter of 2004 to increase by approximately 27% over net income for second quarter 2003, resulting in earnings per share of approximately $0.16 for the second quarter of 2004.”
-MORE-
NRCI Announces First Quarter Results
Page 2
May 4, 2004
A listen-only simulcast of National Research Corporation’s first quarter conference call will be available online atwww.fulldisclosure.com on May 5, 2004, beginning at 11:00 a.m. Eastern time. The online replay will follow approximately two hours later and continue for 30 days.
National Research Corporation, headquartered in Lincoln, Nebraska, is a leading provider of ongoing survey-based performance measurement, analysis, tracking services and improvement services to the healthcare industry. The Company addresses the growing need of healthcare providers and payors to measure the care outcomes, specifically experience and health status, of their patients and/or members. The Company has been at the forefront of the industry in developing tools that enable healthcare organizations to obtain performance measurement information necessary to improve their business practices.
This press release includes “forward-looking” statements related to the Company that can generally be identified as describing the Company’s future plans, objectives or goals. Such forward-looking statements are subject to risks and uncertainties that could cause actual results or outcomes to differ materially from those currently anticipated. These forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. For further information about the factors that could affect the Company’s future results, please see the Company’s filings with the Securities and Exchange Commission.
-MORE-
NRCI Announces First Quarter Results
Page 3
May 4, 2004
NATIONAL RESEARCH CORPORATION
Unaudited Consolidated Statements of Operations
(In thousands, except per share data)
Three Months Ended March 31, | ||||||||
---|---|---|---|---|---|---|---|---|
2004 | 2003 | |||||||
Revenues | $ | 7,561 | $ | 6,058 | ||||
Operating expenses: | ||||||||
Direct expenses | 3,298 | 2,816 | ||||||
Selling, general and administrative | 1,904 | 1,284 | ||||||
Depreciation and amortization | 464 | 446 | ||||||
Total operating expenses | 5,666 | 4,546 | ||||||
Operating income | 1,895 | 1,512 | ||||||
Other income (expense): | ||||||||
Interest income | 82 | 69 | ||||||
Interest expense | (113 | ) | (106 | ) | ||||
Other, net | (10 | ) | 4 | |||||
Total other income (expense) | (41 | ) | (33 | ) | ||||
Income before income taxes | 1,854 | 1,479 | ||||||
Provision for income taxes | 679 | 558 | ||||||
Net income | $ | 1,175 | $ | 921 | ||||
Net income per share, basic | $ | 0.16 | $ | 0.13 | ||||
Net income per share, diluted | $ | 0.16 | $ | 0.13 | ||||
Weighted average shares outstanding: | ||||||||
Basic | 7,256 | 7,249 | ||||||
Diluted | 7,353 | 7,296 |
-MORE-
NRCI Announces First Quarter Results
Page 4
May 4, 2004
NATIONAL RESEARCH CORPORATION
Unaudited Consolidated Condensed Balance Sheets
(Dollars in thousands)
March 31, 2004 | Dec. 31, 2003 | |||||||
---|---|---|---|---|---|---|---|---|
ASSETS | ||||||||
Current Assets: | ||||||||
Cash and cash equivalents | $ | 5,226 | $ | 3,441 | ||||
Short-term investments | 12,515 | 12,767 | ||||||
Accounts receivable, net | 3,418 | 5,479 | ||||||
Other current assets | 2,345 | 1,834 | ||||||
Total current assets | 23,504 | 23,521 | ||||||
Net property and equipment | 12,827 | 12,189 | ||||||
Other, net | 9,931 | 9,963 | ||||||
Total Assets | $ | 46,262 | $ | 45,673 | ||||
LIABILITIES AND SHAREHOLDERS' EQUITY | ||||||||
Current Liabilities: | ||||||||
Accounts payable and accrued expenses | $ | 1,495 | $ | 1,074 | ||||
Deferred revenue | 4,157 | 4,439 | ||||||
Accrued compensation | 858 | 805 | ||||||
Notes payable | 146 | 142 | ||||||
Income taxes payable | 648 | 244 | ||||||
Total current liabilities | 7,304 | 6,704 | ||||||
Noncurrent liabilities | 6,427 | 6,545 | ||||||
Total Liabilities | 13,731 | 13,249 | ||||||
Shareholders' Equity: | ||||||||
Common stock, $0.001 par value; 20,000,000 shares authorized; | ||||||||
7,653,120 and 7,639,819 shares issued, respectively; | ||||||||
7,244,120 and 7,305,819 outstanding, respectively | 8 | 8 | ||||||
Additional paid-in capital | 18,975 | 18,875 | ||||||
Retained earnings | 17,007 | 15,831 | ||||||
Unearned compensation | (402 | ) | (394 | ) | ||||
Accumulated other comprehensive income | 10 | (27 | ) | |||||
Treasury stock | (3,067 | ) | (1,869 | ) | ||||
Total shareholders' equity | 32,531 | 32,424 | ||||||
Total Liabilities and Shareholders' Equity | $ | 46,262 | $ | 45,673 | ||||
-END-